These four top companies all have data that could move the shares the rest of this year and into 2018. All have been around for years and will remain sector leaders for…
The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa and Zynga.
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and…
The Dow Jones Industrial Average closed essentially flat on Friday, with Nike and Merck posting the largest losses and Goldman Sachs and Cisco Systems putting up the biggest gains.
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.
United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
The Commerce Department reports that more than 15 million jobs could be affected by self-driving cars, many major hedge funds have sold shares of Apple and Facebook, and more headlines.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
